Skip to content

Multi-dose Ibuprofen Prophylaxis for IUD-insertion

Multi-dose Ibuprofen Prophylaxis for IUD-insertion (MIPI): A Triple Blinded

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03868137
Acronym
MIPI
Enrollment
86
Registered
2019-03-08
Start date
2020-09-28
Completion date
2022-05-31
Last updated
2020-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IUD, Pelvic Pain

Keywords

NSAID, Intrauterine Devices, Ibuprofen, Pelvic pain

Brief summary

This study compares the effectiveness of decreasing pain at time of and day after intrauterine device (IUD) insertion when patients take three doses of Ibuprofen versus three doses of placebo.

Detailed description

Ibuprofen is commonly used over the counter and prescribed for pain relief such as menstrual cramps. Intrauterine (IUD) insertion can cause pain during and after the insertion. Currently, studies have found that single dose of Ibuprofen take prior to IUD insertion does decrease pain at time of IUD insertion. This study will examine whether 3 doses of Ibuprofen can decrease pain at time of and 1 day after IUD insertion.

Interventions

DRUGIbuprofen

3 doses of Ibuprofen 800 mg

DRUGPlacebos

Placebo

Sponsors

Orlando VA Medical Center
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

A randomization sequence will be generated and given to the research pharmacist who will dispense the appropriate medications to the participants in each arm. Only the pharmacist will know which patient is in which trial arm until the study has ended and data has been analyzed.

Intervention model description

Triple blind randomized control trial involving placebo arm and intervention arm (Ibuprofen)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age ≥ 18 * Female * Able to provide informed consent * English speaking * Able to provide telephone and address contact information * Able and willing to receive HIPAA compliant telephone texts and phone messages * Stable (the same) address and phone number within the last 6 months.

Exclusion criteria

* Contraindications to IUD insertion (active pelvic infection, current pregnancy) * Contraindications to NSAIDs (allergy, history of asthma, history of aspirin allergy, history of kidney disease, history of stomach ulcer, history of active GI bleeding, history of liver disease) * Not undergoing any other concurrent office procedures

Design outcomes

Primary

MeasureTime frameDescription
Pain at time of IUD insertionAt time of IUD insertionPain score measured on 10 point visual analog scale (VAS): 0-3 mild pain, 4-7 moderate pain, 8-10 severe pain

Secondary

MeasureTime frameDescription
Pain at 1 day after IUD insertion1 day after IUD insertionPain score measured on 10 point visual analog scale (VAS): 0-3 mild pain, 4-7 moderate pain, 8-10 severe pain
Usage of other medications or methods to decrease post-IUD insertion pain1 day after IUD insertionNames of other medications or methods

Countries

United States

Contacts

Primary ContactChensi Ouyang, MD
chensi.ouyang@va.gov407-631-1000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026